ShareValue scores for 688098.SHG: Valuation 39, Quality 35, Growth 30, Health 50.
688098.SHGSSE
Shanghai Shen Lian Biomedical Corp
CN¥8.61
(+2.38%)
688098.SHGSSE
Shanghai Shen Lian Biomedical Corp
CN¥8.61(+2.38%)
Loading chart...
Sentiment
Verdicts
Value:Overvalued
Quality:Weak
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
-7% to 10%
Rating
Trap Risk
Return
-7% to 10%
Valuation
39
Overvalued
Price vs Value
Quality
35
Weak
Business Strength
Growth
30
Weak
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
42
Neutral
Price Trend
Company Details
About
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.
Market Cap$3.54B
P/E RatioN/A
Dividend YieldNone
Sector Rank#2681
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026